Physician profile
Neda Hashemi
NPI 1487725784
$3,799.31
in general payments reported to CMS, 2019-2025
34 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $339 · 2021: $593 · 2022: $543 · 2023: $1,336 · 2024: $326 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,083 · Gift: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,082.96 |
| Gift | $810.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $810.00 | 2023 | Da Vinci Surgical System |
| Abbvie INC. | $699.86 | 2019-2023 | |
| Aspira Women'S Health INC | $198.53 | 2021-2023 | Ova1 |
| Mayne Pharma Commercial LLC | $187.06 | 2022-2025 | |
| Optumhealth Care Solutions, LLC | $184.86 | 2023-2025 | Eitan Medical, Vivify Health Care Team Portal 001, Vivify Health Care Team Portal |
| Exeltis, USA INC. | $153.09 | 2021-2023 | Slynd |
| Therapeuticsmd, INC. | $150.88 | 2019-2022 | |
| Astellas Pharma US INC | $142.43 | 2023-2025 | Veozah |
| Evofem Biosciences, INC. | $104.16 | 2020-2023 | Phexxi |
| Bayer Healthcare Pharmaceuticals INC. | $95.03 | 2019-2025 | |
| Organon LLC | $92.86 | 2022-2024 | Nexplanon |
| Hologic Sales and Service, LLC | $91.68 | 2019-2023 | Aptima |
| Coopersurgical, INC. | $91.63 | 2020-2025 | Paragard T 380a |
| Exact Sciences Corporation | $86.97 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sage Therapeutics, LLC | $86.03 | 2021-2025 | Zurzuvae |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renovia INC | $81.34 | 2021 | |
| Daiichi Sankyo INC. | $74.00 | 2020-2021 | |
| Avion Pharmaceuticals | $64.59 | 2021-2023 | Balcoltra |
| Lumenis, INC | $53.10 | 2021 | |
| Roche Diagnostics Corporation | $41.67 | 2019-2021 | |
| Ethicon US, LLC | $39.52 | 2020 | |
| Myovant Sciences INC. | $34.46 | 2021-2022 | |
| Allergan, INC. | $28.42 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $24.08 | 2023 | Myfembree |
| Dexcom, INC. | $24.01 | 2025 | Dexcom G6 Transmitter |
| Davol INC. | $20.21 | 2025 | Arista |
| Amag Pharmaceuticals, INC. | $18.79 | 2019 | |
| Dysis Medical, INC. | $18.55 | 2021 | |
| Hologic INC | $18.39 | 2021 | |
| Vertical Pharmaceuticals, LLC | $18.07 | 2019 | |
| Scynexis, INC. | $17.23 | 2022 | |
| Pfizer INC. | $16.20 | 2023 | |
| Mission Pharmacal Company | $15.82 | 2019 | |
| Abbott Laboratories | $15.79 | 2024 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neda Hashemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.